Increasing prevalence of epistaxis is expected to boost growth of the nasal packing devices market
According to a research article published in International Journal of Otolaryngology in 2015, epistaxis is estimated to affect around 10-12% of the total world population, out of which around 80% patients require medical attention as majority of epistaxis cases are not self-limiting and cannot be resolved due to intervention. Increasing number of nosebleeds cases are expected to foster growth of the nasal packaging device market. Epistaxis is a commonly encountered clinical condition that results in uncertain nose bleeding from either of the nostrils. The most common cause for epitaxies is hypertension. Cardiovascular disorders lead to hypertension, which in turn is favoring growth of the nasal packaging device market. According to the Medical Statistics of World Health Organization (WHO) in 2015, an estimated 289,000 cases of hypertension were reported among pregnant women. According to the American Pregnancy Organization, the circulatory system expands during pregnancy so as to accommodate the baby. The expansion leads to increase in creation and circulation of blood that may lead to problematic issues and frequent nosebleeds during pregnancy. Thus, increasing number of pregnant women suffering from hypertensive diseases is expected to boost growth of the global nasal packing devices market over the forecast period. Moreover, increasing number of patients suffering from nasal tumors benign or malignant also contributes to the nasal packing devices market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients